Virchows Archiv A

, Volume 419, Issue 2, pp 79–88 | Cite as

Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels

  • E. Vollmer
  • J. Brust
  • A. Roessner
  • A. Bosse
  • F. Burwikel
  • B. Kaesberg
  • B. Harrach
  • H. Robenek
  • W. Böcker
Original Articles

Summary

Atherosclerotic vessels were analysed histochemically for distribution, quantity, and composition of apolipoprotein (Apo) types in the vascular wall. The specimens comprised all stages of atherosclerosis, from very discrete intimal changes to complicated lesions. The vessel specimens were marked with antibodies against human Apo A1, A2, and B. Apo A1 can be demonstrated in even the earliest stage of atherosclerosis, and increases with the progression of the disease. In the initial stage, Apo A1 is found first in lumen-adjacent layers of the intima, and is evident in deeper layers of the wall as the disease progresses. Arteries of muscular type show accumulation of Apo in an earlier stage (or in greater quantity at the same stage) than arteries of elastic type. At all stages, the amount of Apo A1 always exceeds that of A2 and B. In the intima, Apo B is higher than Apo A2, the media contains hardly any Apo B, and the adventitia has less B than A2. Within the intimal layer, Apo A1 and A2 are found in an intracellular (mainly in foam cells) or in an extracellular location, according to the stage of atherosclerosis. Apo B is almost exclusively extracellular; only cases of advanced atherosclerosis show some intracellular localization (mostly in foam cells), visualized as electron dense lamellar organelles, probably of lysosomal origin. In the media, Apo A1 and A2 are accumulated in intracellular deposits, whereas the extracellular storage of Apo A1 A2 and B is observed only in cases with the most severe damage. Our investigations suggest that the accumulation of apolipoproteins in the vascular wall is effected not only by insudation from the plasma, but also by neosynthesis and/or metabolism by locally derived cells or cells immigrating in the process of atherosclerosis. The presence of Apo A1 and A2 in the vessel wall is now documented, and their role at this site apparently differs from that in the plasma.

Key words

Atherosclerosis Apolipoprotein A1, A2, B Immunohistochemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Assmann G (1982) Lipidstoffwechsel und Atherosklerose. Schattauer, StuttgartGoogle Scholar
  2. Avogaro P, Bittolo-Bon G, Cazzolato G (1978) Plasma levels of apolipoprotein A1 and apolipoprotein B in human atherosclerosis. Artery 4:385–394Google Scholar
  3. Avogaro P, Bittolo-bon G, Quici GB (1979) Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet I:901–903Google Scholar
  4. Brown MS, Goldstein JL (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223–261Google Scholar
  5. Carter RS, Siegel RJ, Chai AU, Fishbein MC (1987) Immunhistochemical localization of apolipoproteins A1 and B in human carotid arteries. J Pathol (Lond) 153:31–36Google Scholar
  6. de Chastonay G, Gabbiani G, Elemer G, Hüttner I (1983) Remodeling of the rat aortic endothelial layer during experimental hypertension. Lab Invest 48:45–52Google Scholar
  7. Feldman DL, Hoff HF, Gerrity RG (1984) Immunhistochemical localization of apoprotein B in aortas from hyperlipemic swine. Arch Pathol Lab Med 108:817–822Google Scholar
  8. Gerrity RG (1981) The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 103:181–200Google Scholar
  9. Glenn KC, Ross R (1981) Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion of endotoxin and concavalin A. Cell 25:603–615Google Scholar
  10. Goldstein JL, Brown MS (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 46:897–930Google Scholar
  11. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoproteins as a protective factor against coronary heart disease: Framingham study. Am J Med 62:707–714Google Scholar
  12. Gotto AM, Jackson RL (1978) Plasma lipoproteins and atherosclerosis. Atherosclerosis Rev 3:231–242Google Scholar
  13. Harrach B, Robenek H (1990) Polyclonal antibodies against prefixed apolipoprotein A-1: an approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry. Arteriosclerosis 10:564–576Google Scholar
  14. Haimovici H (1977) Atherogenesis. Recent biological concepts and clinical implications. Am J Surg 134:174–178Google Scholar
  15. Hoff HF, Gaubatz JW (1975) Ultrastructural localization of plasma lipoproteins in human intracranial arteries. Virchows Arch [A] 369:111–121Google Scholar
  16. Hoff HF, Heideman CL, Jackson BL, Bayardo RJ, Kim HS, Gotto AM (1975a) Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res 37:72–79Google Scholar
  17. Hoff HF, Lie JT, Titus JL, Bajardo RJ, Jackson RL, De Bakey ME, Gotto AM (1975b) Lipoproteins in atherosclerotic lesions. Arch Pathol Lab Med 99:253–258Google Scholar
  18. Hüttner I, Costabella P, de Chastomay C, Gabbiani G (1982) Volume, surface and junctions of rat aortic endothelium during experimental hypertension: a morphometric and freeze fracture study. Lab Invest 46:489–504Google Scholar
  19. Jellinek H, Detre Z (1986) Role of the altered transmural permeability in the pathomechanism of arteriosclerosis. Pathol Res Pract 181:693–712Google Scholar
  20. Lipid Research Clinics Program (1984) The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365–374Google Scholar
  21. Maciejko JJ, Holmed DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJT (1983) Apolipoprotein A1 as a marker of angiographically assessed coronary artery disease. N Engl J Med 309:385–389Google Scholar
  22. Mahley RW (1981) Cellular and molecular biology of lipoprotein metabolism in atherosclerosis. Diabetes 30:60–65Google Scholar
  23. Mawhinney TP, Augustyn JM, Fritz KE (1978) Glycosaminogly-canlipoprotein complexes from aortas of hypercholesterolemic rabbits. I. Isolation and characterization. Atherosclerosis 31:155–167Google Scholar
  24. Miller GJ (1980) High density lipoproteins and atherosclerosis. Annu Rev Med 31:97–108Google Scholar
  25. Mora R, Lupu F, Simionescu N (1989) Cytochemical localization ofβ-lipoproteins and their components in successive stages of lyperlipidemic atherogenesis of rabbit aortas. Atherosclerosis 79:183–195Google Scholar
  26. Nakashima Y, Matsushima T, Takahara K, Kuroiwa A, Nakamura M (1985) The analysis of lipids and glycosaminoglycans of low-density-lipoprotein-glycosaminoglycan complexes isolated from normal, fatty streaks, and fibrous plaque of human aortic intima. Int Angiol 4:487–493Google Scholar
  27. Niendorf A, Rath M, Wolf K, Peters S, Arps H, Beisiegel U, Dietel M (1990) Morphological detection and quantification of lipoprotein (a) deposition in atheromatous lesions of human aorta and coronary arteries. Virchows Arch [A] 417:105–111Google Scholar
  28. Patsch JR (1987) Lipide. In: Wick G, Schwarz S, Förster O, Peterlik (Eds) Funktionelle Pathologic. Fischer, Stuttgart, pp 430–445Google Scholar
  29. Rogers KA, Hoover RL, Castellot JJ, Robinson JM, Karnovsky MJ (1986) Dietary cholesterol-induced changes in macrophage characteristics. Relationship to atherosclerosis. Am J Pathol 125:284–291Google Scholar
  30. Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314:488–500Google Scholar
  31. Schmitz G, Robenek H, Assmann G (1987) Role of high-density lipoprotein receptor cycle in macrophage cholesterol metabolism. Atherosclerosis Rev 16:95–107Google Scholar
  32. Simionescu N (1979) Enzymatic tracers in the study of vascular permeability. J Histochem Cytochem 27:1120–1130Google Scholar
  33. Smith EB (1990) Transport, interactions and rotation of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J 11 [Suppl E]:72–81Google Scholar
  34. Smith EB, Staples EM (1980) Distribution of plasma proteins across the human aortic wall. Atherosclerosis 27:578–590Google Scholar
  35. Srinivasan SR, Vijayagopal P, Dalfers ER, Abbate B, Radhakrishnamurty B, Berenson GS (1986) Low density lipoprotein retention by aortic tissue. Atherosclerosis 62:201–208Google Scholar
  36. Stary HC (1983) Macrophages in coronary artery, in aortic intima, and in atherosclerotic lesions of children and young adults up to age 29. In: Schettler FG, Gotto AM, Middelhoff G, Habenicht ARJ, Jurutka KR (eds) Sixth International Symposium on Atherosclerosis. Springer Publishing, New York, pp 462–466Google Scholar
  37. Stary HC (1987) Evolution and progression of atherosclerosis in the coronary arteries of children and adults. In: Bates SR, Gangloff ED (eds) Atherogenesis and aging. Springer, New York Berlin Heidelberg, pp 20–36Google Scholar
  38. Stary HC (1990a) Changes in the cells of atherosclerotic lesions as advanced lesions evolve in coronary arteries of children and young adults. In: Glagov S, Newman WP, Schaffer SA (eds) Pathobiology of the human atherosclerotic plaque. Springer, Berlin Heidelberg New York, pp 93–106Google Scholar
  39. Stary HC (1990b) The sequence of cell and matrix changes in atherosclerotic lesions in the first forty years of life. Eur Heart J 11 [Suppl E]:3–19Google Scholar
  40. Stössel JP (1980) Wie entsteht Arteriosklerose? Med Klin 75:348–357Google Scholar
  41. van Stiphout WAHJ, Hofman A, Kruijssen HACM, Vermeeren R, Groot PHE (1986) Is the ratio of apo B/apo A1, an early predictor of coronary atherosclerosis? Atherosclerosis 62:179–182Google Scholar
  42. Vasile E, Simionescu M, Simionescu N (1983) Visualization of the binding endocytosis and transcytosis of low density lipoprotein in the arterial endothelium in situ. J Cell Biol 96:1677–1689Google Scholar
  43. Vergani C, Trovato G, Dioguardi N (1978) Serum total lipids, lipoproteins, cholesterol, apoproteins A and B in cardiovascular disease. Clin Chim Acta 87:127–133Google Scholar
  44. Vijayagopal P, Srinivasan SR, Radhakrishnamurty B, Berenson GS (1981) Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem 256:8234–8241Google Scholar
  45. Vollmer E, Roessner A, Bosse A, Käsberg B, Robenek H, Sorg C, Winde G, Böcker W (1991) Immunohistochemical double labelling of macrophages, smooth muscle cells, and apolipoprotein E in the atherosclerotic plaque. Pathol Res Pract 187:184–188Google Scholar
  46. Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T (1985) Role of macrophages in atherosclerosis. Lab Invest 53:80–90Google Scholar
  47. Wolfbauer G, Glick JM, Minor LK, Rothblat GH (1986) Development of the smooth muscle foam cell: Uptake of macrophage lipid inclusions. Proc Natl Acad Sci USA 83:7760–7764Google Scholar
  48. Ylä-Herttuala S, Solakivi T, Hirvonen J, Laaksonen H, Möttönen M, Pesonen E, Raekallio J, Akerblom HK, Nikkari T (1987) Glycosaminoglycans and apolipoproteins B and A1 in human aortas. Arteriosclerosis 7:333–340Google Scholar
  49. Yomantas S, Elner VM, Schaffner T, Wissler RW (1984) Immunhistochemical localization of apilopiprotein B in human atherosclerotic lesions. Arch Pathol Lab Med 108:374–378Google Scholar
  50. Yost C, Herman IM (1988) Age-related and site-specific adaptation of the arterial endothelial cytoskeleton during atherogenesis. Am J Pathol 130:595–604Google Scholar
  51. Yutani C, Go S, Imakita M, Ishibashi-Ueda H, Hatanaka K, Yamamoto A (1987) Autopsy findings in two patients with homozygous familial hypercholesterolemia. Special reference to apolipoprotein B localization and internalization defect of low density lipoprotein. Acta Pathol Jpn 37:1489–1504Google Scholar
  52. Zwadlo G, Bröcker EB, Bassewitz DB von, Feige U, Sorg C (1985) A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134:1487–1492Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • E. Vollmer
    • 1
  • J. Brust
    • 1
  • A. Roessner
    • 1
  • A. Bosse
    • 1
  • F. Burwikel
    • 1
  • B. Kaesberg
    • 2
  • B. Harrach
    • 2
  • H. Robenek
    • 2
  • W. Böcker
    • 1
  1. 1.Gerhard-Domagk-Institut für PathologieMünsterGermany
  2. 2.Institut für ArterioskleroseforschungMünsterGermany

Personalised recommendations